Regulation

Germany Circumvents EU Policies By Taking Phased Approach to Legalizing Weed

mm
Published
Updated
Add MyCannabis.com to your preferred sources on Google

Barely a week ago, Germany announced plans to scale back on cannabis legalization plans so as not to be in conflict with EU laws. Germany being a member of the EU is beholden to the Single Convention on Narcotic Drugs of 1961 which forbids the production, trade, or use of cannabis except for medicinal or research purposes. A few days later, Allemagne has come up with a bi-phasic approach that will circumvent EU regulations altogether. 

Phase 1

Germany will allow adults above 18 years to cultivate up to 3 cannabis plants per residence. The country will also allow for the creation of cannabis social clubs (similar to Malta cannabis social clubs) that will provide members with up to 5 cannabis plants per member. These clubs will have a maximum enrolment of 500 members and will operate as not-for-profit entities. The possession and consumption of small amounts of cannabis in private residences will be legal. 

Phase 2

The German government will launch pilot projects to trial commercial cultivation and domestic supply chains of cannabis. The government will also conduct field research and evaluations on the proposed full legalization plans. This phase will take five years. 

The first will be introduced in parliament later in April and the next bill for phase two should be introduced around October, 2023.

Germany has had a lot of back and forth in its plans to legalize recreational cannabis. This phased approach might provide a way out for Germany to circumvent the tough EU regulations on cannabis. As well as other narcotics. Germany’s legalization plan will cause a ripple effect through Europe since Germany is the largest economy.

mm

Lydia K. (Bsc. RN) is a cannabis writer, which, considering where you’re reading this, makes perfect sense. Currently, she is a regular writer for Mace Media. In the past, she has written for MyBud, RX Leaf & Dine Magazine (Canada), CBDShopy (UK) and Cannavalate & Pharmadiol (Australia). She is best known for writing epic news articles and medical pieces. Occasionally, she deviates from news and science and creates humorous articles. And boy doesn't she love that! She equally enjoys ice cream, as should all right-thinking people.